Skip to main content
. Author manuscript; available in PMC: 2016 Mar 28.
Published in final edited form as: J Offender Rehabil. 2014 Sep 16;53(7):543–561. doi: 10.1080/10509674.2014.944739

Table 2.

RMC-WO Cost Analysis Results

Aggregate Phase 1: Phase 2:
Annual Costs1 First 90 Days Post-release2 3–36 Months Post-release 3
Resource Category OM-only OM-plus-RMC OM-only OM-plus-RMC plus HIV interv. OM-only OM-plus-RMC
Personnel 34,544 53,444 5,182 13,361 29,363 40,083
Contractors 3,711 5,898 557 1,474 3,154 4,423
Supplies 10,593 23,967 1,589 5,992 9,004 17,975
Travel 502 494 75 123 427 370
Participant 5,445 5,355 817 1,339 4,628 4,016
Other/Miscellaneous 1,592 4,723 239 1,181 1,353 3,542
Indirect (34.8%) 19,623 32,837 2,943 8,209 16,679 24,628
Total Economic Cost 76,010 126,717 11,401 31,679 64,608 95,038

Average Economic Cost per N Average Cost N Average Cost N Average Cost N Average Cost N Average Cost N Average Cost

Quarter (weighted)4 239 80.8 236 136.9 78 164.5 79 461.3 229 75.7 224 113.2
OM Interview Completed 884 86.0 862 147.0 152 75.0 151 209.8 732 88.3 711 133.7
Intervention Session Completed –– –– 785 161.4 –– –– 134 236.4 –– –– 651 146.0

Notes: dashed line indicates not applicable (N/A).

1

Aggregate annual cost is calculated as the sum of total costs during the first 90 days and the average monthly cost over months 4 to 33 of the intervention times 9 (to provide a 12 month perspective on intervention costs). Based on steady state year of 2010.

2

Phase 1 represents the first 90 days of the RMC intervention. RMC costs during this phase include a specialized HIV intervention (Wechsberg et al., 2004) delivered at months 1, 2, and 3.

3

Phase 2 reflects intervention activities beyond the first 90 days. The cost estimates represent average quarterly costs for a nine-month period based on total intervention costs over months 4 to 33.

4

To estimate the average cost per quarter, participation in 2010 was weighted based on the actual months of participation in intervention activities during Phase 1 and Phase 2.